Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The released interleukin 2 receptor binds interleukin 2 efficiently.

L A Rubin, G Jay, D L Nelson

    Journal of Immunology (Baltimore, Md. : 1950)
    |December 15, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Efficacy of a new schistosomicidal agent 2-[(methylpropyl)amino]-1-octanethiosulfuric acid against an oxamniquine resistant Schistosoma mansoni isolate.

    Memorias do Instituto Oswaldo Cruz·1999
    Same author

    Regulation and function of WASp in platelets by the collagen receptor, glycoprotein VI.

    Blood·1999
    Same author

    Retrovirus-mediated WASP gene transfer corrects defective actin polymerization in B cell lines from Wiskott-Aldrich syndrome patients carrying 'null' mutations.

    Gene therapy·1999
    Same author

    Alternative splicing in the murine and human FXR1 genes.

    Genomics·1999
    Same author

    The thrombocytopenia of Wiskott Aldrich syndrome is not related to a defect in proplatelet formation.

    Blood·1999
    Same author

    Cue set size effects: sampling activated associates or cross-target interference?

    Memory & cognition·1999
    Same journal

    Complement C3 deficiency increases the effector and cytotoxic functions of NK cells and suppresses tumor growth.

    Journal of immunology (Baltimore, Md. : 1950)·2026
    Same journal

    Increased Nur77 is disconnected from TCR affinity in insulin-specific Tregs.

    Journal of immunology (Baltimore, Md. : 1950)·2026
    Same journal

    FTR85 negatively regulates type I IFN antiviral signaling pathway by promoting K48-linked polyubiquitination of IRF3.

    Journal of immunology (Baltimore, Md. : 1950)·2026
    Same journal

    An MR1-specific nanobody capable of blocking MR1T cell activation.

    Journal of immunology (Baltimore, Md. : 1950)·2026
    Same journal

    TGF-β controls developmental fate and functional identity of thymic γδ T cells.

    Journal of immunology (Baltimore, Md. : 1950)·2026
    Same journal

    Distinguishing Th17 cells as a unique subset.

    Journal of immunology (Baltimore, Md. : 1950)·2026
    See all related articles

    Researchers characterized the released interleukin 2 receptor (IL 2R), finding it is a glycoprotein that binds to IL 2. This suggests a role for soluble IL 2R in regulating IL 2-dependent lymphocyte functions.

    Area of Science:

    • Biochemistry
    • Immunology
    • Molecular Biology

    Background:

    • The interleukin 2 receptor (IL 2R) is crucial for T cell activation and proliferation.
    • Soluble forms of IL 2R are detected in biological fluids, but their structure and function are not fully understood.

    Purpose of the Study:

    • To characterize the biochemical structure of the released IL 2R.
    • To determine the functional capacity of the released IL 2R.
    • To investigate the interaction between released IL 2R and interleukin 2.

    Main Methods:

    • Enzymatic digestions were used to analyze the glycoprotein structure.
    • Affinity chromatography was employed to assess binding to recombinant IL 2.
    • Characterization was performed on released IL 2R from HTLV-I-positive T cell lines and PHA-activated lymphocytes.

    Related Experiment Videos

    Main Results:

    • The released IL 2R is a complex glycoprotein with N- and O-linked carbohydrates and sialic acid residues.
    • Its peptide backbone is smaller than the cell surface IL 2R.
    • Released IL 2R efficiently binds to recombinant IL 2 without accessory molecules.

    Conclusions:

    • The released IL 2R shares structural similarities with the cell surface receptor but has a smaller peptide core.
    • The binding of released IL 2R to IL 2 suggests a role in modulating IL 2 signaling.
    • Soluble IL 2R may play a significant role in regulating IL 2-dependent lymphocyte functions.